Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 5, 2001, Pages 1581-1584

  Valdezate, S ^a   Vindel, A ^a   Loza, E ^a   Baquero, F ^a   Canton R ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CHLORAMPHENICOL; CLINAFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; KANAMYCIN; LATAMOXEF; MEROPENEM; MINOCYCLINE; NETILMICIN; PEFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TICARCILLIN; TIMENTIN; TOBRAMYCIN; TROVAFLOXACIN; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STENOTROPHOMONAS MALTOPHILIA; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; STENOTROPHOMONAS MALTOPHILIA;

EID: 0035041053     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.5.1581-1584.2001     Document Type: Article

References (24)

1. Two consecutive outbreaks of Stenotrophomonas maltophilia (Xanthomonas maltophilia) in an intensive-care unit defined by restriction fragment-length polymorphism typing
2. Multiple antibiotic resistance in Stenotrophomonas maltophilia
3. Stenotrophomonas maltophilia D457R contains a cluster of genes from gram-positive bacteria involved in antibiotic heavy metal resistance
4. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates
5. Genotypic and phenotypic relationships between clinical and environmental isolates of Stenotrophomonas maltophilia
6. Comparison of various in vitro susceptibility methods for testing Stenotrophomonas maltophilia
7. Microbiology and clinical aspects of infection associated with Stenotrophomonas maltophilia
8. Evidence of nosocomial Stenotrophomonas maltophilia cross-infection in a neonatology unit analyzed by three molecular typing methods
9. Genomic diversity of the genus Stenotrophomonas
10. Macrolides for the treatment of Pseudomonas aeruginosa infections?
11. Susceptibility testing of Stenotrophomonas maltophilia to carbapenems
12. Characterization of the chromosomal aac(6′)-Iz gene of Stenotrophomonas maltophilia
13. Susceptibility of 100 strains of Stenotrophomonas maltophilia to three β-lactams and five β-lactam-βlactamase inhibitor combinations
14. In vitro activities of β-lactam-β-lactamase inhibitor combinations against Stenotrophomonas maltophilia: Correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity
15. Performance standards for antimicrobial susceptibility testing
16. Susceptibilities of 123 strains of Xanthomonas maltophilia to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin
17. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing
18. Antibiotic susceptibility of Stenotrophomonas maltophilia (Xanthomonas maltophilia): Comparative (NCCLS criteria) evaluation of antimicrobial drugs with agar dilution and the agar disk diffusion (Bauer-Kirby) test
19. Comparative in vitro activity of quinolones against Stenotrophomonas maltophilia
20. Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998
21. Sequence analysis and enzyme kinetics of the L2 serine β-lactamase from Stenotrophomonas maltophilia
22. Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia
23. The barrier function of the outer membrane of Pseudomonas maltophilia in the diffusion of saccharides and beta-lactam antibiotics
24. Multiple antibiotic resistance in Stenotrophomonas maltophilia: Involvement of a multidrug efflux system